Millipore Sigma Vibrant Logo

SCC483 HCC95 Human Lung Squamous Carcinoma Cell Line

Among the NSCLC cell lines, HCC95 has been shown to retain the lung squamous carcinoma (LUSC) disease phenotype. Early research showed that HCC95 is very similar to the original tumor genetically and histochemically, with poor differentiation and formation of keratinization. Collectively, these demonstrate that HCC95 is a valuable cell line for modeling LUSC with high fidelity in vitro. A 2010 study has exemplified its use in studying NSCLC sensitivity to cisplatin treatment.

View This Product on Sigma-Aldrich
SCC483
≥1X10⁶ cells/vial   
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberSCC483
      DescriptionHCC95 Human Lung Squamous Carcinoma Cell Line
      Alternate Names
      • HCC95 cell line
      • Human lung carcinoma cell line
      • Lung squamous carcinoma cell line
      • Hamon Cancer Center 95
      • Human lung squamous carcinoma cell line
      • LUSC cell line
      Background InformationLung cancer is the leading cause of cancer death, causing 23% of all cancer mortality in 2020. Among all lung cancer cases, 85% are categorized as non-small cell lung cancer (NSCLC) which is a heterogeneous group of diseases with poor prognosis and a 5-year survival rate of less than 20%. Among all NSCLC cases, 30-40% are categorized as lung squamous carcinoma (LUSC) which often affects the main airways and bronchi and is attributed to smoking as its principal etiology.

      The HCC95 cell line is a human lung squamous cell carcinoma line, collected from a metastatic site of pleural effusion. Recent transcriptomic characterizations show that HCC95 show high similarity to the typical LUSC transcriptome.



      Source
      HCC95 human squamous lung carcinoma cells were derived from a 65-year-old male with NSCLC.

      References
      1. J Natl Compr Canc Netw. 2013, 11(6): 645–653 DOI: 10.6004/jnccn.2013.0084
      2. Nat Rev Cancer 2014, 14(8): 535–546 DOI: 10.1038/nrc3775
      3. J Thorac Dis. 2013, 5(Suppl 5): S463–S478 DOI: 10.3978/j.issn.2072-1439.2013.08.43
      4. J Clin Oncol. 2010, 28(36): 5311–5320 DOI: 10.1200/JCO.2010.28.8126
      5. Clin Can Res. 1999, 5(5): 991-1000
      6. Nat Commun. 2019, 10(1): 3574 DOI: 10.1038/s41467-019-11415-2
      7. J Cancer Res Clin Oncol 2010, 136(4): 493–502 DOI: 10.1007/s00432-009-0681-6
      References
      Product Information
      Components
      • ≥1x106 viable HCC95 Lung Squamous Carcinoma Cancer Cells: (Catalog No. SCC483). Store in liquid nitrogen.
      Quality LevelMQ100
      Applications
      ApplicationAmong the NSCLC cell lines, HCC95 has been shown to retain the lung squamous carcinoma (LUSC) disease phenotype. Early research showed that HCC95 is very similar to the original tumor genetically and histochemically, with poor differentiation and formation of keratinization. Collectively, these demonstrate that HCC95 is a valuable cell line for modeling LUSC with high fidelity in vitro. A 2010 study has exemplified its use in studying NSCLC sensitivity to cisplatin treatment.
      Key Applications
      • Cell Based Assays
      • Cell Culture
      • Cell Function Assay
      • Chemotaxis
      • Pharmaceutical
      Application NotesThis product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.
      Biological Information
      HostHuman
      Cell Line Type
      • Cancer Cells
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality Assurance• Each vial contains ≥ 1X106 viable cells.
      • Cells are tested negative for infectious diseases by a Human Essential CLEAR Panel by Charles River Animal Diagnostic Services.
      • Cells are verified to be of human origin and negative for interspecies contamination from mouse, rat, Chinese hamster, Golden Syrian hamster, and nonhuman primate (NHP) as assessed by a Contamination Clear panel by Charles River Animal Diagnostic Services
      • Cells are negative for mycoplasma contamination.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsHCC95 cells should be stored in liquid nitrogen. The cells can be cultured for at least 10 passages without significantly affecting cell marker expression and function.
      Packaging Information
      Material Size≥1X10⁶ cells/vial
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      SCC483 04065268968956